Key factors such growing geriatric population, increasing number of hospitals in emerging markets, and high prevalence of chronic diseases are the major factors driving the growth of the needles market across the globe.
The Needles Market is expected to reach USD 8.47 Billion by 2022, at CAGR of 7.8% during the forecast period. Ask for PDF Brochure: -https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=223979930 Market Segmentation:- On the basis of type, the global needles market is segmented into two broad categories, namely, conventional needles and safety needles. The conventional needles market is estimated to command the larger share of the global needles market in 2017. The growing demand for biosimilar products, the increasing incidence of chronic disease, and the expanding injectables market are the key factors contributing to the growth of this market segment. Based on product, the market is segmented into suture needles, blood collection needles, ophthalmic needles, dental needles, insufflation needles, pen needles, and other needles. The needles market is segmented into hypodermic, intravenous, intramuscular, and intraperitoneal needles on the basis of delivery mode. The hypodermic needles segment is expected to account for the largest share of the needles market in 2017. Key Market Drivers: – 1 High Prevalence of Chronic Diseases 2 Growing Geriatric Population 3 Increasing Number of Hospitals in Emerging Markets 4 Increasing Demand for Vaccines Regional Analysis: - As of 2016, North America held the largest share of the global needles market, followed by Europe. Its dominant share is attributed to the rising incidence of chronic diseases, initiatives by different organizations for the reduction in blood borne infections and increasing prevalence of cardiovascular diseases. Request for Sample Pages: -https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=223979930 Top Key Players: - The key players in the global needles market are Hamilton Company (U.S.), Medtronic plc (Ireland), Becton, Dickinson and Company (U.S.), Stryker Corporation (U.S.), B. Braun Melsungen AG (Germany), Boston Scientific Corporation (U.S.), Terumo Corporation (Japan), Novo Nordisk A/s (Denmark), Smiths Medical (U.K.), and Thermo Fisher Scientific (U.S.).
0 Comments
Market growth is largely driven by the rapidly growing global geriatric population. The elderly are more susceptible to various diseases and disorders such as orthopedic, dental, neurological, and cardiovascular disorders, owing to which, growth in the geriatric population will result in an increase in the demand for implants. The growing number of accidents and sports-related injuries and the increasing launch of technologically advanced products are also major factors supporting market growth.
The global Medical Alloys Market is projected to reach USD 17.6 billion by 2024 from USD 11.2 billion in 2019, at a CAGR of 9.4%. Ask for PDF Brochure: -https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=256117768 By type, the titanium segment is expected to account for the largest share of the metal implants and medical alloys market in 2019 On the basis of type, the titanium segment is expected to account for the largest share of the metal implants and medical alloys market in 2019. The large share of this segment can be attributed to the advantages offered by titanium, such as high biocompatibility, strength, rigidity, greater strain-bearing capacity, and greater corrosion-resistance properties as compared to other materials. Moreover, it is non-allergic, non-magnetic, and non-radio-opaque, and adheres easily to the bone without any additional coating. By application, the orthopedic applications segment is expected to grow at the highest CAGR during the forecast period (2019–2024) Based on application, the metal implants and medical alloys market is segmented into orthopedic, cardiovascular, dental, craniomaxillofacial, and neurological applications. The orthopedic applications segment is expected to grow at the highest CAGR in the metal implants and medical alloys market during the forecast period owing to the growing incidence of orthopedic disorders such as osteoporosis and arthritis, which result in a large patient pool for orthopedic implant procedures. North America to dominate the metal implants and medical alloys market in 2019 North America is expected to account for the largest share of the metal implants and medical alloys market in 2019, followed by Europe and the Asia Pacific. The large share of North America in the global market can be attributed to the growing aging population and subsequent increase in the prevalence of chronic disorders in North American countries, thereby increasing demand for improved products and treatment services. Other factors supporting market growth include the growing healthcare expenditure, high accessibility to advanced technologies in countries such as the US and Canada, increasing focus on the development of innovative and technologically advanced products, and the significant presence of major product developers in the region. Request for Sample Pages: - https://www.marketsandmarkets.com/requestsampleNew.asp?id=256117768 The prominent players in the metal implants and medical alloys market are Carpenter Technology Corporation (US), Royal DSM (Netherlands), Johnson Matthey Plc (UK), ATI Specialty Alloys & Components (US), Ametek Specialty Products (US), Aperam S.A. (Luxembourg), QuesTek Innovations LLC (US), and Fort Wayne Metals (US). The key factors driving the growth of this market are the growing prevalence of chronic diseases (such as cancer, diabetes, and cardiovascular diseases), favorable reimbursement scenario in major markets, and technological advancements in injector devices.
The Wearable Injectors Market is projected to reach USD 9.41 billion by 2023 from USD 5.57 billion in 2018, at a CAGR of 11.1% during the forecast period. Ask for PDF Brochure: - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=100771004 Market Segmentation:- On the basis of type, the Wearable Injectors Industry is segmented into on-body and off-body injectors. The on-body injectors segment is expected to account for the larger market share in 2018, while the off-body injectors segment is projected to witness the highest growth rate during the forecast period. The drawbacks associated with on-body wearable injectors, such as painful removal, skin sensitivity issues and irritation, and adhesive fitting issues have resulted in the increased adoption of off-body injectors. On the basis of therapy, the wearable injectors market is segmented into immuno-oncology, diabetes, cardiovascular diseases, and other therapies (Parkinson’s disease, thalassemia, and primary immunodeficiency disorders). In 2018, the immune-oncology segment is expected to account for the largest share of the wearable injectors market. This can be attributed to the high prevalence of cancer across the globe. Recent Developments:-
Regional Analysis:- In 2018, North America is expected to account for the largest share of the wearable injectors market, followed by Europe. Request for Sample Pages: - https://www.marketsandmarkets.com/requestsampleNew.asp?id=100771004 Top Key Players: - The key players in the global Wearable Injectors Industry are Amgen (US), Medtronic (Ireland), Insulet Corporation (US), Tandem Diabetes Care (US), United Therapeutics Corporation (US), Valeritas (US), and SteadyMed Therapeutics (US). The other prominent players in this market are Ypsomed (Switzerland), Becton, Dickinson and Company (US), Enable Injections (US), Sensile Medicals (Switzerland), and Bespak (UK). Which are the top industry players in the APAC medical device outsourced manufacturing market?5/21/2021 The Asia Pacific medical device outsourced manufacturing market is mainly driven by the overall growth of the medical devices market, mainly due to the rising disease prevalence, life expectancy, and geriatric population. Technological advancements have prompted end users to overhaul or update their manufacturing systems. As this is a costly process, they look to outsource contract manufacturing. The report Medical Device Outsourced Manufacturing Market is projected to reach USD 56.2 billion by 2026 from USD 29.3 billion in 2021 and is expected to grow at a CAGR of 13.9% during the forecast period. Ask For PDF Brochure :- https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=477468 The IVD devices segment accounted for the largest share of Asia Pacific medical device outsourced manufacturing market in 2020 Based on device type, the Asia Pacific medical device outsourced manufacturing market is broadly segmented into IVD devices, diagnostic imaging devices, cardiovascular devices, drug delivery devices, orthopedic devices, respiratory care devices, ophthalmology devices, surgical devices, diabetes care devices, dental devices, endoscopy devices, gynecology/urology devices, personal care devices, neurology devices, and other devices. In 2020, the IVD devices segment accounted for the largest share of the Asia Pacific medical device outsourced manufacturing market. The large share of this segment can be attributed to the increasing volume of IVD tests performed globally, increasing availability of IVD kits and reagents in the market, a growing number of hospitals and clinical laboratories in developing countries, automation and technological advancements in instruments with high-throughput capabilities, high demand for IVD tests in the COVID-19 pandemic, and advances in life science research. Class II medical devices segment accounted for the largest share of APAC medical device outsourced manufacturing market in 2020. Based on the class of device, the medical device outsourced manufacturing market is segmented into Class I, Class II, and Class III medical devices. In 2020, the Class II medical devices segment accounted for the largest share of the Asia Pacific medical device outsourced manufacturing market. The large share of this segment can be attributed to the large number of medical devices outsourced that fall under this device class and the utilization of a higher volume of these devices by end users and caregivers in the healthcare industry. In 2020, device development and manufacturing services segment accounted for the largest share of the Asia Pacific medical device outsourced manufacturing market Based on service, the Asia Pacific medical device outsourced manufacturing market is segmented into device development and manufacturing services, quality management services, packaging and assembly services and other services. In 2020, the device development and manufacturing services segment dominated this market. The increasing adoption of contract manufacturing services in the medical device industry, growth in the medical devices market (especially in the single-use disposable medical devices market), and improving device development and manufacturing capabilities are the major factors responsible for the large share of this segment In 2020, production segment accounted for the largest share of Asia Pacific medical device outsourced manufacturing market Based on process, the Asia Pacific medical device outsourced manufacturing market is broadly segmented into production, prototyping, pilot production, design for manufacturing, process evaluation, validation, project management, packaging, and assembly. In 2020, the production segment accounted for the largest share of the medical device outsourced manufacturing market. The large share of this segment can be attributed to the growing number of medical device companies outsourcing their production tasks to minimize manufacturing costs. China is expected to witness fastest growth during the forecast period of 2021–2026. The Asia Pacific medical device outsourced manufacturing market, by country, has been segmented into China, Japan, Malaysia & Singapore, India, Australia & New Zealand, South Korea, and the Rest of APAC. China is expected to witness fastest growth during the forecast period of 2021–2026. Request for Sample Pages :- https://www.marketsandmarkets.com/requestsampleNew.asp?id=477468 Top Key Players :- The prominent players in this market are Flex, Ltd. (Singapore), Jabil, Inc. (US), TE Connectivity, Ltd. (Switzerland), Sanmina Corporation (US), Nipro Corporation (Japan), Celestica International (Canada), Plexus Corporation (US), Benchmark Electronics, Inc. (US), Integer Holdings Corporation (US), Gerresheimer Ag (Germany), West Pharmaceutical Services, Inc. (US), Nortech Systems, Inc. (US), Consort Medical PLC (UK), Kimball Electronics Inc. (US), and Teleflex Incorporated (US), Nordson Corporation (US), Tecomet, Inc. (US), SMC Ltd. (US), Nemera (France), and Tessy Plastics Corporation (US), among others. The major factors driving the growth of the laboratory balances and scales market are the technological advancements in laboratory balances and scales; increasing research investments and activities among pharma-biotech companies and CROs; increasingly stringent regulatory framework for product safety in bio-pharmaceutical industries; implementation of stringent food safety guidelines; and emerging markets.
The global Laboratory Balances and Scales Market is projected to reach USD 1.6 billion by 2023 from USD 1.3 billion in 2018, at a CAGR of 3.7%. Ask for PDF Brochure: - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=166668097 The analytical balances segment is expected to account for the largest share of the laboratory balances market, by product type, in 2018 Based on product type, the laboratory balances market is segmented into micro & ultra-micro balances, top loading/precision balances, analytical balances, portable/compact balances, moisture analyzers, and other balances. The analytical balances segment is expected to account for the largest share of the laboratory balances and scales market in 2018. The increasing adoption of analytical balances among biopharmaceutical industries, owing to its procedural benefits (such as portability, easy to operate, less weighing time, high durability, low cost, and high precision) is the major factor driving the growth of this market segment. The bench scales segment is expected to witness high growth rate in the laboratory scales market, by product type, in 2018 Based on product type, the laboratory scales market is segmented into bench scales, counting scales, compact scales, and other scales. The bench scales segment is expected to witness high growth rate in the laboratory scales market in 2018. The increasing adoption of laboratory scales among bio-pharmaceutical industry due to the procedural benefits offered by these instruments, such as flow-thru design ensures protection from liquids, touchless sensors, minimum stabilization time, ease of handling, and fast measurement time is the major factor driving the growth of this market segment. Pharmaceutical, cosmeceutical, and biotechnology product testing laboratories to account for the largest share of the global balances and scales market during the forecast period Based on end user, the laboratory balances and scales market is segmented into pharmaceutical, cosmeceutical, and biotechnology product testing laboratories; chemical and material testing laboratories; food and beverage testing laboratories; petroleum product testing laboratories; research laboratories & academic institutes, and other end users. The pharmaceutical, cosmeceutical, and biotechnology product testing laboratories segment is expected to account for the largest share during the forecast period. North America to dominate the laboratory balances and scales market during the forecast period The laboratory balances and scales market is segmented into four regional segments, namely, North America, Europe, Asia Pacific, and the Rest of the World. The North America region is expected to account for the largest share of the global laboratory balances and scales market in 2018, and this trend is expected to continue during the forecast period. Request for Sample Pages: - https://www.marketsandmarkets.com/requestsampleNew.asp?id=166668097 The major players operating in the laboratory balances and scales market are A&D Company, Ltd (Japan), Metler Toledo international, Inc. (US), Sartorius AG (Germany), Shimadzu Corporation (Japan), PCE Instruments (UK), Kern & Sohn GmbH (Germany), RADWAG Balances and Scales (Poland), Adam Equipment Co. (UK), Avery Weigh-Tronix, LLC (UK), Bonso Electronics International, Inc. (China), Essae Group (India), and Gram Precision S.L (Spain). The growing number of outpatient surgeries is expected to increase the adoption of capnography monitoring devices in outpatient surgical departments in the US.
The US Outpatient Surgical Procedures Market is expected to grow from ~129 million procedures in 2018 to ~144 million procedures by 2023, at a CAGR of 2.1% during the forecast period. Ask for PDF Brochure: - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=94756744 The dental surgeries segment is expected to command the largest share of the overall outpatient surgical procedures market in the US during the forecast period. By type, the dental surgeries segment accounted for the largest share of the US outpatient surgical procedures market in 2018. The large share of this market segment can be attributed to the large number of dental surgeries performed in physicians’ offices in the US, which require minimal sedation. The other surgeries segment is expected to grow at the highest CAGR during the forecast period. Other surgeries performed in outpatient departments include surgeries of the nervous system (laminectomy and excision of the intervertebral disc and decompression of the peripheral nerve), endocrine system (partial or complete thyroidectomy), and integumentary system (mastectomy and lumpectomy). Request for Sample Pages: - https://www.marketsandmarkets.com/requestsampleNew.asp?id=94756744 Growth in this market segment can largely be attributed to the increasing prevalence of disorders of the intervertebral disc, peripheral nerves, and glands as well as growth in the burden of breast cancer. Market growth can be attributed to factors such as rising incidence of burns, increasing healthcare expenditure, favorable government initiatives, increasing number of emergency centers and burn units, and growing awareness regarding treatment options. The global Burn Care Market is expected to reach USD 2.33 Billion by 2021 from USD 1.68 Billion in 2016, at a CAGR of 6.8% from 2016 to 2021. Ask for PDF Brochure:-https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=247121470 Market Segmentation:- In this report, the burn care market has been segmented on the basis of product, depth of burn, end user, and region. Based on product, the market is segmented into advanced burn care, biologics, traditional burn care, and other burn care products. The advanced burn care products segment includes alginate dressings, collagen dressings, hydrogel dressings, hydrocolloid dressings, wound contact layers, film dressings, and foam dressings. Based on the depth of burn, the burn care market is segmented into minor, partial-thickness, and full-thickness burns. The partial-thickness burns segment is expected to account for the largest share in 2016, owing to the increasing usage of advanced dressings and biologics such as skin grafts and substitutes. On the basis of end users, the burn care market is segmented into hospitals, physician clinics, home care and other end users. The hospitals segment is expected to account for the largest share of the global burn care market in 2016. Key market Drivers: – 1 Rising Incidence of Burn Injuries 2 Advancements in Burn Care Products 3 Rising Awareness on Burn Care 4 Increasing Healthcare Expenditure Regional Analysis:- Based on regions, the burn care market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). North America is expected to account for the largest share of the market in 2016. Request for Sample Pages: - https://www.marketsandmarkets.com/requestsampleNew.asp?id=247121470 Top key Players: - Key players in the burn care market include Smith & Nephew plc (U.K.), Mölnlycke Health Care (Sweden), Convatec Inc. (U.K.), Acelity L.P. (U.S.), Coloplast A/S (Denmark), Derma Sciences, Inc. (U.S.), Medtronic (Ireland), and 3M Company (U.S.). The growth in this market is mainly driven by the shift from standalone to hybrid modalities, advances in radiotracers, the increasing focus on personalized medicine, investments through public-private partnerships to modernize diagnostic imaging centers, and the increasing incidence and prevalence of cancer and cardiac ailments.
The report Nuclear Imaging Equipment Market is expected to reach USD 3.4 billion by 2025 from USD 2.6 billion in 2020, at a CAGR of 4.9% during the forecast period. Ask for PDF Brochure: - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=98 Market Segmentation: - By product, the SPECT imaging systems segment is expected to account for the largest share of the Nuclear Imaging Equipment market in 2020 Based on product, the nuclear imaging equipment market is segmented into hybrid PET imaging systems, SPECT imaging systems, and planar scintigraphy imaging systems. The SPECT imaging systems segment is further categorized into standalone and hybrid imaging systems. The SPECT imaging systems segment is expected to the largest share in 2019. The large share of this segment can be attributed to high adoption of SPECT imaing systems on account of lower cost as compared to hybrid PET imaging systems, By application, the oncology segment is expected to account for the largest share of the nuclear imaging equipment market in 2020 Based on application, the nuclear imaging equipment market is segmented into oncology, cardiology, neurology, and other applications. The oncology application segment is expected to register the highest CAGR during the forecast period. The major factors contributing to the growth of this segment include the rising incidence and prevalence of cancer across the globe, initiatives taken by public and private organizations to curb the rising cancer prevalence, and the development of advanced systems and radiotracers for oncology. By end-user, the hospitals end-user segment is expected to account for the largest share of the Nuclear Imaging Equipment market in 2020 Based on end user, the nuclear imaging equipment market is segmented into hospitals, imaging centers, academic & research centers, and other end users. Hospitals accounted for the largest share of the global nuclear imaging equipment market in 2019. This can be attributed to factors such as the need to improve the efficiency of diagnostic imaging procedures and the rising number of diagnostic imaging procedures performed in hospitals. Regional Analysis: - North America to dominate the market in 2020 North America, Europe, Asia Pacific, and the Rest of the World (RoW) are the regions considered for geographic analysis of the global nuclear imaging equipment market study. North America is expected to account for the largest share of the global nuclear imaging equipment market. Request for Sample Pages: - https://www.marketsandmarkets.com/requestsampleNew.asp?id=98 Key Market Players: - The prominent players in the global nuclear imaging equipment market include are Siemens Healthineers (Germany), Philips Healthcare (Netherlands), and GE Healthcare (US). The other players in the market include Toshiba Medical Systems Corporation (Japan), Neusoft Medical Systems Co., Ltd. (China), Mediso Medical Imaging Systems Ltd. (Hungary), Digirad Corporation (US), CMR Naviscan Corporation (US), SurgicEye GmbH (Germany), and DDD Diagnostics (Denmark). Factors such as the growing incidence of urolithiasis and technological advancements in lithotripsy devices are driving the growth of this market.
The report Lithotripsy Devices Market is expected to reach USD 1.76 Billion by 2023 from USD 1.41 Billion in 2018, at a CAGR of 4.5%. Ask for PDF Brochure: -https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=29769904 Market Segmentation:- By type, the lithotripsy devices market is classified into extracorporeal shock wave lithotripsy devices and intracorporeal lithotripsy devices. In 2017, the extracorporeal shock wave lithotripsy devices segment accounted for the largest share of the market. ESWL is the least invasive of all stone treatments and is considered the treatment modality of choice for a majority of urinary stones. On the basis of applications, the lithotripsy devices market is categorized into kidney stones, ureteral stones, pancreatic stones, and bile duct stones. In 2017, the kidney stones segment accounted for the largest share of the market. The increasing incidence of kidney stones and the recurrence of these stones over a period of time are the key factors driving the growth of this segment. On the basis of end user, the lithotripsy devices market is categorized into hospitals, ambulatory surgical centers, and other end users. In 2017, the hospitals segment accounted for the largest share of the global lithotripsy devices market. Target Audience for this Report:-
Based on region, the lithotripsy devices market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). North America dominated the lithotripsy devices market in 2017. The large share can primarily be attributed to the high prevalence of kidney stones and the large number of surgeries performed each year. Request for Sample Pages: - https://www.marketsandmarkets.com/requestsampleNew.asp?id=29769904 Top key Players:- Some of the major players in the lithotripsy devices market are Siemens AG (Germany), Boston Scientific (US), Dornier MedTech (Germany), Olympus America (Japan), DirexGroup (Germany), and Richard Wolf (Germany). The growth of the market is attributed to the increasing geriatric population and subsequent growth in global disease incidence, favorable regulations and government initiatives & investments, the advantages of digital X-ray systems, and technological advancements and product development.
The Digital X-ray Market is expected to reach USD 13.04 billion by 2023 from USD 8.68 billion in 2018, at a CAGR of 8.5%. Ask for PDF Brochure: - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=1164 Market Segmentation: - Based on application, the Digital Radiography Market is segmented into general radiography, dental applications, fluoroscopy, and mammography. In 2018, the general radiography segment is expected to account for the largest share of the digital X-ray market. The growth in this market is mainly driven by the rising prevalence of diseases like tuberculosis, osteoporosis, and CVD; growing aging population; and product launches. By technology, the Digital Radiography Market is segmented into direct radiography and computed radiography. The direct radiography segment is expected to register the highest rate during the forecast period. Recent Developments:-
In 2018, North America is expected to dominate the market. The large share of this geographical segment is attributed to factors such strong economies in the US and Canada, which have allowed for significant investments in new technologies. Request for sample Pages :- https://www.marketsandmarkets.com/requestsampleNew.asp?id=1164 Key Players:- The mammography x ray market is highly competitive with the presence of several small and big players. Some of the players in the digital X-ray market are Canon Inc. (Japan), Carestream Health (US), Fujifilm Corporation (Japan), GE Healthcare (US), Hitachi Ltd. (Japan), Hologic, Inc. (US), Philips Healthcare (Netherlands), Shimadzu Corporation (Japan), Siemens Healthineers (Germany), Konica Minolta, Inc. (Japan), Samsung Medison Co., Ltd. (Korea), and Agfa Gevaert (Belgium) |
AuthorWe are providing and consulting the healthcare Industry Research Report. Archives
March 2022
Categories |